Fast Facts: Biosimilars in Hematology and Oncology : Biologics and Biosimilars - Getting Decisions Right
Fast Facts: Biosimilars in Hematology and Oncology : Biologics and Biosimilars - Getting Decisions Right
Click to enlarge
Author(s): Cornes, Paul
ISBN No.: 9781912776214
Pages: 128
Year: 202001
Format: Trade Paper
Price: $ 34.50
Dispatch delay: Dispatched between 7 to 15 days
Status: Available

Biologics have revolutionized - and are revolutionizing - the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars - particularly in curative cancer treatment, where they are relatively recent therapeutic options. 'Fast Facts: Biosimilars in Hematology and Oncology' provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients. Contents: * Biologics and the need for biosimilars * Why do we need biosimilars? * How is the quality of biosimilar medicines assured? * Legal issues * Switching, interchangeability and extrapolation * Safety and pharmacovigilant * Global issues * Formulary considerations: pharmacy issues * Formulary considerations: supportive care biosimilars * Formulary considerations: therapeutic anti-cancer biosimilars * Communication and awareness.


To be able to view the table of contents for this publication then please subscribe by clicking the button below...
To be able to view the full description for this publication then please subscribe by clicking the button below...